|
ACCEPT
American College of Cardiology Evaluation of Preventive Therapeutics
 |
Author(s) |
Pearson TA, Peters TD, Feury D
|
 |
Title(s) |
The American College of Cardiology Evaluation of Preventive Therapeutics (ACCEPT) study: attainment of goals for comprehensive risk reduction in patients with coronary disease in the US
|
|
Reference(s) |
J Am Coll Cardiol 1998;31 Suppl A:186A
|
|
Disease |
Coronary heart disease
|
|
Purpose |
To establish the extent to which American College of Cardiology and American Heart Association guidelines for comprehensive risk reduction in patients with coronary heart disease are implemented in the USA
|
|
Study design |
Prospective
|
|
Follow-up |
6 months
|
|
Patients |
> 5000 consecutive patients admitted for first CABG (26%), first angioplasty (36%), acute MI (23%), or acute myocardial ischaemia (15%)
|
|
Treatment regimen |
N/A |
|
Results |
A substantial proportion of patients still smoked, had elevated BP (> 140/90 mm Hg) or raised LDL cholesterol (> 100 mg/dl) 6 months after discharge. Aspirin usage was widespread, but many patients had not been given beta-blockers, lipid-lowering agents or, in the case of women, oestrogen
|
|
|
|
